Albumin Regeneration in Liver Support—Comparison of Different Methods
- 28 April 2006
- journal article
- research article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 10 (2) , 108-117
- https://doi.org/10.1111/j.1744-9987.2006.00351.x
Abstract
Albumin is the most abundant human plasma protein. Among many other functions it is an important transporter of hydrophobic internal and external substances such as intermediate and end products of metabolism and drugs. In liver failure the albumin binding capacity is decreased because of a disproportion between available albumin molecules caused by decreased hepatic synthesis and hydrophobic toxins because of decreased hepatic clearance. The resulting increase in plasma and tissue concentrations of these substances is associated with multiple organ dysfunctions frequently seen in severe liver failure. The scope of the present article is to compare different liver support strategies with regard to their ability to regenerate the patients albumin pool by removing albumin-bound toxins. Most prominent technique in this group is the molecular adsorbent recirculating system (MARS). It will be compared with single pass albumin dialysis (SPAD), fractionated plasma separation and adsorption system (FPSA, Prometheus), and plasma perfusion/bilirubin adsorption with special regard to efficacy and selectivity.Keywords
This publication has 40 references indexed in Scilit:
- In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separationJournal of Hepatology, 2005
- AnnouncementJournal of Hepatology, 2004
- Prometheus® – a new extracorporeal system for the treatment of liver failure☆Journal of Hepatology, 2003
- Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trialLiver Transplantation, 2003
- Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled studyHepatology, 2002
- Albumin Binding Capacity (ABiC) is reduced in commercially available Human Serum Albumin preparations with stabilizersZeitschrift für Gastroenterologie, 2001
- Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trialLiver Transplantation, 2000
- PLASMA SEPARATION AND BILIRUBIN ADSORPTION AFTER COMPLICATED LIVER TRANSPLANTATIONTransplantation, 1998
- In Vivo and In Vitro Evaluation of Bilirubin Removal in Postoperative Hyperbilirubinemia PatientsArtificial Organs, 1995
- Application of Plasma Perfusion in Hepatic FailureBiomaterials, Artificial Cells and Immobilization Biotechnology, 1991